Le Lézard
Classified in: Health, Covid-19 virus
Subject: SVY

Pharmacy Groups: CMS Guidance Sets Up Oral Antivirals for Failure, Limiting Patients' Access to COVID-19 Treatments


WASHINGTON, Nov. 30, 2021 /PRNewswire/ -- A group of six pharmacy organizations today criticized the decision of the U.S. Centers for Medicare & Medicaid Services (CMS) to only "encourage" but not require payment to pharmacists for testing, patient assessment, ordering/prescribing and dispensing for oral COVID-19 antiviral drugs, potentially limiting the ability of Medicare patients to access these lifesaving medications? particularly those in rural and underserved communities.

Pharmacy Groups: CMS Oral Antivirals Guidance limits patient's access to COVID-19 Treatment

The issue is extremely time sensitive, because a committee of the Food and Drug Administration meeting today to determine whether to issue an Emergency Use Authorization for molnupiravir, an oral antiviral medication developed by Merck.

The group stated, "After more than a year of continuously expanding the ability of patients to access COVID-19 tests, immunizations, and therapeutics from pharmacists and other pharmacy personnel, the failure of CMS to require pharmacists to be compensated for testing, patient assessment, and ordering/prescribing, in addition to dispensing oral antivirals makes little sense and sets up the distribution program for failure. 

"CMS needs to clearly delineate a payment pathway necessary to allow pharmacists' patients to access these lifesaving medications. Ninety percent of Americans live within five miles of a pharmacy, making them the most viable access point for patients to receive these medications. In addition, the neighborhood pharmacy in rural and underserved communities may be the only health care provider for miles.

"The federal government has made it clear we need all-hands-on-deck to defeat COVID-19 and advance health equity by authorizing pharmacists and other pharmacy personnel to order and administer oral antivirals. Without hesitation, throughout the pandemic, our nation's frontline pharmacists have stepped up to meet the public health needs of our patients."

Supporting organizations:
American Pharmacists Association
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
College of Psychiatric and Neurologic Pharmacists
National Alliance of State Pharmacy Associations
National Community Pharmacists Association

SOURCE ASHP (American Society of Health-System Pharmacists)


These press releases may also interest you

at 19:59
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

at 17:50
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...

at 17:30
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...

at 17:10
Teradyne, Inc. reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor...

at 17:00
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...

at 16:57
Ball Corporation's board of directors (the "Board") today declared a cash dividend of 20 cents per share, payable June 17, 2024, to shareholders of record as of June 3, 2024. In addition, the board also approved the repurchase by the company of up...



News published on and distributed by: